Literature DB >> 11123101

Progress in systemic sclerosis: novel therapeutic paradigms.

J Varga1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123101     DOI: 10.1007/s11926-000-0024-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  21 in total

1.  Alpha interferon-2a (Roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study. UK Systemic Sclerosis Study Group.

Authors:  W Stevens; R Vancheeswaran; C M Black
Journal:  Br J Rheumatol       Date:  1992-10

2.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.

Authors:  P J Sime; Z Xing; F L Graham; K G Csaky; J Gauldie
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

Authors:  A Grassegger; G Schuler; G Hessenberger; B Walder-Hantich; J Jabkowski; W MacHeiner; W Salmhofer; B Zahel; G Pinter; M Herold; G Klein; P O Fritsch
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

4.  In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.

Authors:  J George; D Roulot; V E Koteliansky; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

5.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

Authors:  D E Clouthier; S A Comerford; R E Hammer
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Treatment of systemic sclerosis with gamma-interferon.

Authors:  R Hein; J Behr; M Hündgen; N Hunzelmann; M Meurer; O Braun-Falco; A Urbanski; T Krieg
Journal:  Br J Dermatol       Date:  1992-05       Impact factor: 9.302

7.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Authors:  R Ziesche; E Hofbauer; K Wittmann; V Petkov; L H Block
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

8.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.

Authors:  T J Broekelmann; A H Limper; T V Colby; J A McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors:  Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.